Newborn screening for developmental disabilities: reframing presumptive benefit.

Area of Science:

• Public Health
• Genetics
• Developmental Pediatrics

Background:

• Newborn screening (NBS) traditionally focuses on direct medical benefits for infants.
• Current NBS practices for developmental disabilities often do not meet this strict medical benefit standard.
• There's a need to re-evaluate the definition of benefit in the context of NBS.

Purpose of the Study:

• To argue for an expanded concept of presumptive benefit in newborn screening.
• To highlight the value of early intervention programs accessible through NBS.
• To advocate for considering broader societal and consumer-driven benefits of NBS.

Main Methods:

• Literature review and ethical analysis of current NBS practices.
• Examination of consumer perspectives on health information and treatable disorders.
• Policy analysis regarding the expansion of NBS targets.

Main Results:

• NBS facilitates access to early intervention services that positively impact child development.
• Consumers possess a broader definition of 'treatable disorder' than policymakers.
• NBS offers societal benefits beyond direct medical outcomes for infants.

Conclusions:

• The concept of presumptive benefit in NBS should be broadened to include early intervention and developmental support.
• Consumer desires for health information and reproductive risk assessment are key considerations.
• Expanding NBS targets is warranted when considering overall societal benefits, provided ethical and legal issues are addressed.